Gastrointestinal cancer: Keeping aFLOaT with new combination
Sign Up to like & getrecommendations! Published in 2017 at "Nature Reviews Clinical Oncology"
DOI: 10.1038/nrclinonc.2016.186
Abstract: early stage gastric tumours (T1), but those with advanced-stage tumours (T2–4) or regional lymph-node involvement have a poor prognosis. Perioperative chemotherapy regimens containing epirubicin, cisplatin and fluorouracil (ECF) or epirubicin, cisplatin and capecitabine (ECX) can… read more here.
Keywords: ecf ecx; group; gastrointestinal cancer; cancer keeping ... See more keywords